Related Experiment Video
Updated: Jul 16, 2026
04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
Thyroid arterial embolization to treat Graves' disease
1Medical Imaging Center and Department of Endocrinology, First Affiliated Hospital, Kunming Medical College, Kunming, China.
Acta Radiologica (Stockholm, Sweden : 1987)
|March 14, 2007
Summary
Thyroid arterial embolization effectively treated hyperthyroid Graves' disease in 78.6% of patients, leading to euthyroid states. This minimally invasive procedure offers a promising alternative for managing hyperthyroidism.
Area of Science:
- Endocrinology
- Interventional Radiology
Background:
- Graves' disease is a common cause of hyperthyroidism.
- Thyroid arterial embolization is an emerging treatment modality.
Purpose of the Study:
- To evaluate the efficacy and safety of thyroid arterial embolization for hyperthyroid Graves' disease.
Main Methods:
- Prospective study of 28 patients with Graves' disease.
- Thyroid arterial embolization performed on 22 or three arteries.
- Hormonal and autoimmune markers monitored for 12-22 months.
Main Results:
- 78.6% of patients achieved euthyroid state; 17.8% showed improvement.
- Temporary fluctuations in thyroid hormones and TSH observed post-procedure.
- Thyroid antibodies showed transient changes, normalizing within 2 months.
Conclusions:
- Thyroid arterial embolization is a safe and effective treatment for hyperthyroid Graves' disease.
- The procedure demonstrates significant potential for long-term disease management.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...